Next Article in Journal
Pilot Implementation of Falsified Medicines Directive in Hospital Pharmacy to Develop Best Practices for Medicine Decommissioning Process
Next Article in Special Issue
Oncology Pharmacists Can Reduce the Projected Shortfall in Cancer Patient Visits: Projections for Years 2020 to 2025
Previous Article in Journal
The Prescribing and Education of Naloxone in a Large Academic Medical Center
Previous Article in Special Issue
The Hematopoietic Cell Transplant Pharmacist: A Call to Action
Open AccessArticle

Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic

Indiana University Health Simon Cancer Center, Indianapolis, IN 46202, USA
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(1), 32; https://doi.org/10.3390/pharmacy8010032
Received: 20 February 2020 / Revised: 3 March 2020 / Accepted: 6 March 2020 / Published: 8 March 2020
Recent advancements in molecular testing, the availability of cost-effective technology, and novel approaches to clinical trial design have facilitated the implementation of tumor genome sequencing into standard of care oncology practices. Current models of precision oncology practice include specialized clinics or consultation services based on a molecular tumor board (MTB) approach. MTBs are comprised of interprofessional teams of clinicians and scientists who evaluate tumors at the molecular level to guide patient-specific targeted therapy. The practice of precision oncology utilizing MTB-based models is an emerging approach, transforming precision genomics from a novel concept into clinical practice. This rapid shift in practice from cytotoxic therapy to targeted medicine poses challenges, yet brings exciting opportunities to clinical pharmacists practicing in hematology and oncology. Only a few precision genomics programs in the United States have a strong pharmacy presence with oncology pharmacists serving in leadership roles in research, interpreting genomic sequencing, making treatment recommendations, and facilitating off-label drug procurement. This article describes the experience of the precision medicine clinic at the Indiana University Health Simon Cancer Center, with emphasis on the role of the pharmacist in the precision oncology initiative. View Full-Text
Keywords: precision genomics; precision medicine; precision oncology; targeted therapy; oncology pharmacist; molecular tumor board; next generation sequencing precision genomics; precision medicine; precision oncology; targeted therapy; oncology pharmacist; molecular tumor board; next generation sequencing
Show Figures

Figure 1

MDPI and ACS Style

Raheem, F.; Kim, P.; Grove, M.; Kiel, P.J. Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic. Pharmacy 2020, 8, 32.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop